Collaborative efforts are essential to tackle TB and protect global health.

As the world continues to grapple with the ongoing COVID-19 pandemic, it may come as a surprise to many that tuberculosis has now taken the lead as the deadliest infectious disease. With 1.25 million lives lost in 2023 and 10.8 million people infected globally, TB has once again emerged as a major threat to public health.

Caused by Mycobacterium tuberculosis, TB primarily affects the lungs but can also harm other organs, spreading through the air and disproportionately impacting low-income countries. The symptoms of TB include a persistent cough, chest pain, night sweats, and weight loss. While TB is preventable and curable in most cases, it remains a significant challenge, particularly for those with HIV or limited access to healthcare.

In response